Vitamin D and Omega-3 Inhibit Metabolic Syndrome

Last updated: June 12, 2013
Sponsor: University of Guelph
Overall Status: Completed

Phase

3

Condition

Obesity

Diabetes Prevention

Williams Syndrome

Treatment

N/A

Clinical Study ID

NCT01326442
2011MeckVitD
  • Ages 18-65
  • All Genders

Study Summary

The study will test the hypothesis that supplementing the diet of subjects with Metabolic Syndrome with 2000 IU vitamin D and 1.8 g omega-3 fatty acids (EPA + DHA) per day, will facilitate weight loss, improve body composition and reduce metabolic and biochemical risk factors associated with type II diabetes and cardiovascular disease. Adult men and women who meet the International Diabetes Federation criteria for Metabolic Syndrome will be enrolled and embark on a 16 week diet and exercise intervention using a low glycemic index diet with or without the supplementary vitamin D and omega-3. Subjects will be counseled weekly and blood collected at weeks 0 and 16.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • must have Metabolic Syndrome as defined by International Diabetes Federation

  • must be able to swallow tablets and capsules

  • must be 18 years of age or older

  • must be physically capable of moderate intensity exercise

Exclusion

Exclusion Criteria:

  • pregnant or lactating

  • vegetarian

Study Design

Total Participants: 40
Study Start date:
April 01, 2011
Estimated Completion Date:
December 31, 2012

Connect with a study center

  • University of Guelph

    Guelph, Ontario N1G2W1
    Canada

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.